Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
Because the original research concerned the gut, PLIVA tested it in the bowel disease ulcerative colitis, given as an enema, in a randomized, placebo-controlled study [11]
Ingredients are sourced from carefully vetted, FDA-inspected facilities
The first GLP-1 analogue to be approved for the treatment of obesity in Switzerland was liraglutide in 2017
Exenatide once weekly can cause transient small nodules at the injection site
A doctor can provide dosage information tailored to your individual needs
US$ 20.65
US$ 28.44
:max_bytes(150000):strip_icc()/HEALTH-DWL-frame-final-4-83ab587c91ea4eab9e89a0e86add8e41.jpg)
US$ 20.37
US$ 28.62
US$ 29.86
